Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
Clinical trial NCT06355037 · UNKNOWN
Trial details
- NCT number
- NCT06355037
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2024-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.